Ossiam’s AstraZeneca AZN Stock Holding History

Ossiam’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Sell	80,256 -4,864	-6%	-$915K	0.2%	79
2026 Q1	$16.5M	Buy	+85,120	New	+$16.4M	0.29%	54

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ossiam's AZN Position: Q2 2026 in Review

Ossiam reduced its AstraZeneca (AZN) stake by 5.7% in Q2 2026, selling an estimated $915K and leaving 80,256 shares worth $15M. The position accounts for 0.2% of the portfolio, ranked #79.

Ossiam first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.5M in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Ossiam held 80,256 shares of AstraZeneca worth $15M as of Q2 2026.
Ossiam sold 4,864 AstraZeneca shares in Q2 2026, an estimated $915K.
AstraZeneca made up 0.2% of Ossiam's portfolio in Q2 2026, its #79 holding.
Ossiam first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Ossiam's AstraZeneca position peaked at $16.5M in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.